Stay updated on Upadacitinib in Active Ankylosing Spondylitis Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib in Active Ankylosing Spondylitis Clinical Trial page.

Latest updates to the Upadacitinib in Active Ankylosing Spondylitis Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedNo core study content was altered; formatting and UI changes were made that do not affect the study details, eligibility criteria, outcomes, or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedUpdate: publication date changed from August 28, 2025 (Online ahead of print) to August 28, 2025 with the notice removed; the entry now reflects the standard citation without the Online ahead of print note. Core bibliographic details remain the same.SummaryDifference0.2%

- Check41 days agoChange DetectedPage updated to Revision: v3.2.0 from Revision: v3.0.2; indicates a new release version with no other substantive content changes.SummaryDifference0.0%

- Check42 days agoChange DetectedUpdated revision tag from v3.0.2 to v3.1.0. No substantive changes to core content detected.SummaryDifference0.0%

- Check49 days agoChange DetectedRemoved explicit mentions of drug safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs), reducing emphasis on safety/regulatory content.SummaryDifference0.1%

- Check57 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; 'Back to Top' link removed. No substantive content changes detected.SummaryDifference0.1%

Stay in the know with updates to Upadacitinib in Active Ankylosing Spondylitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib in Active Ankylosing Spondylitis Clinical Trial page.